| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...993046G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0093046 |
| P932 | PMC publication ID | 3989178 |
| P698 | PubMed publication ID | 24740004 |
| P5875 | ResearchGate publication ID | 261750086 |
| P50 | author | Xiaosheng Wang | Q82275863 |
| P2093 | author name string | Chittibabu Guda | |
| Lindsey Ludwig | |||
| Nalin C W Goonesekere | |||
| P2860 | cites work | Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies | Q21198792 |
| An overview of Cdk1-controlled targets and processes | Q21203553 | ||
| Genetic progression and the waiting time to cancer | Q21563505 | ||
| Proteome-based biomarkers in pancreatic cancer | Q43008803 | ||
| Lck is a key target of imatinib and dasatinib in T-cell activation | Q43165902 | ||
| Promoter hypomethylation and upregulation of trefoil factors in prostate cancer. | Q43180971 | ||
| The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma | Q43873030 | ||
| Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness | Q44567936 | ||
| Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas | Q44582125 | ||
| Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. | Q44582763 | ||
| S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. | Q44664669 | ||
| Aberrant Stratifin Overexpression Is Regulated by Tumor-Associated CpG Demethylation in Lung Adenocarcinoma | Q45244925 | ||
| Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer | Q45285518 | ||
| A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments | Q48364889 | ||
| S100P is a novel marker to identify intraductal papillary mucinous neoplasms | Q51915095 | ||
| Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis | Q52594636 | ||
| RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis | Q57016872 | ||
| Multiple-laboratory comparison of microarray platforms | Q57248479 | ||
| Regulation of I B Kinase Expression by the Androgen Receptor and the Nuclear Factor- B Transcription Factor in Prostate Cancer | Q58325218 | ||
| Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer | Q60594558 | ||
| Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer | Q77965516 | ||
| Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation | Q80013098 | ||
| Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies | Q82681266 | ||
| The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration | Q84023421 | ||
| Association of GPX1 polymorphism, GPX activity and prostate cancer risk | Q84259385 | ||
| Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study | Q24301198 | ||
| Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
| Aneuploidy: cancer's fatal flaw? | Q24595815 | ||
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
| A decade of exploring the cancer epigenome — biological and translational implications | Q24614467 | ||
| Distant metastasis occurs late during the genetic evolution of pancreatic cancer | Q24624284 | ||
| A census of human cancer genes | Q24647081 | ||
| When 2+2=5: the origins and fates of aneuploid and tetraploid cells | Q24658364 | ||
| Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function | Q27660495 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study | Q28204291 | ||
| ONCOMINE: a cancer microarray database and integrated data-mining platform | Q28255103 | ||
| Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer | Q28273473 | ||
| Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells | Q28279630 | ||
| S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature) | Q28279641 | ||
| Tissue repair and stem cell renewal in carcinogenesis | Q28294006 | ||
| AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness | Q28505514 | ||
| The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells | Q28591182 | ||
| Epiplakin accelerates the lateral organization of keratin filaments during wound healing | Q28593212 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Patterns of somatic mutation in human cancer genomes | Q29547841 | ||
| The causes and consequences of genetic heterogeneity in cancer evolution | Q29615848 | ||
| UniProt Knowledgebase: a hub of integrated protein data | Q29615864 | ||
| Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments | Q29616371 | ||
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles | Q29617464 | ||
| The patterns and dynamics of genomic instability in metastatic pancreatic cancer | Q29618121 | ||
| Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 | ||
| Collagen reorganization at the tumor-stromal interface facilitates local invasion | Q30478870 | ||
| Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. | Q30795307 | ||
| Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes | Q30883294 | ||
| Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes | Q30989925 | ||
| Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers | Q33268089 | ||
| Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. | Q33280165 | ||
| Key issues in conducting a meta-analysis of gene expression microarray datasets | Q33366123 | ||
| RankProdIt: A web-interactive Rank Products analysis tool | Q33651591 | ||
| Proteomics in pancreatic cancer research | Q33791981 | ||
| Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer | Q37412311 | ||
| Linking somatic genetic alterations in cancer to therapeutics | Q37425870 | ||
| Histone deacetylase inhibitors: design, structure-activity relationships and therapeutic implications for cancer | Q37550592 | ||
| The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver | Q37643391 | ||
| A new era: melanoma genetics and therapeutics | Q37815139 | ||
| Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview | Q37824829 | ||
| Exploring the Genomes of Cancer Cells: Progress and Promise | Q37857590 | ||
| Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment | Q37889585 | ||
| Calcium-binding protein S100P and cancer: mechanisms and clinical relevance | Q37938716 | ||
| New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression | Q37948607 | ||
| Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application | Q37962623 | ||
| Inherited variations in the SOD and GPX gene families and cancer risk | Q37976875 | ||
| An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies | Q38448664 | ||
| Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis | Q38819898 | ||
| Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor κB and signal transducer and activator of transcription 3 | Q39340284 | ||
| Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors. | Q39342008 | ||
| Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. | Q39489740 | ||
| Characterizing DNA methylation patterns in pancreatic cancer genome. | Q39842549 | ||
| Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma | Q39978912 | ||
| Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. | Q40330646 | ||
| Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues | Q40657562 | ||
| Signal transduction through NF-kappa B. | Q41724478 | ||
| Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. | Q42163115 | ||
| LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer | Q33848195 | ||
| Molecular Signatures of Pancreatic Cancer | Q33918801 | ||
| Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. | Q33933880 | ||
| Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors | Q33948970 | ||
| Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine | Q34026669 | ||
| Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates | Q34088416 | ||
| Developing c-MET pathway inhibitors for cancer therapy: progress and challenges | Q34089725 | ||
| Global analysis of DNA methylation in early-stage liver fibrosis | Q34142428 | ||
| Matrix metalloproteinases in tumorigenesis: an evolving paradigm. | Q34199345 | ||
| CTHRC1 is upregulated by promoter demethylation and transforming growth factor‐β1 and may be associated with metastasis in human gastric cancer | Q34275314 | ||
| Current status of molecular markers for early detection of sporadic pancreatic cancer | Q34458903 | ||
| Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation | Q34471573 | ||
| Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding | Q34533007 | ||
| Tyrphostins and other tyrosine kinase inhibitors | Q34535133 | ||
| Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers | Q34538752 | ||
| A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion | Q34583126 | ||
| Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control | Q34773400 | ||
| LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis | Q34935319 | ||
| Correlation of mRNA and protein in complex biological samples. | Q35009100 | ||
| Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms | Q35024882 | ||
| The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma | Q35558563 | ||
| Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery | Q35631111 | ||
| DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas | Q35985285 | ||
| Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis | Q36075240 | ||
| Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation | Q36407079 | ||
| Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity | Q36605447 | ||
| Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study | Q36615561 | ||
| Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia | Q36681931 | ||
| Mechanisms and insights into drug resistance in cancer | Q36682301 | ||
| Transforming growth factor-beta signaling in cancer invasion and metastasis | Q36938077 | ||
| Oncogenic transformation and experimental models of human cancer | Q36991697 | ||
| Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle | Q37315780 | ||
| Disease signatures are robust across tissues and experiments | Q37379502 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| biomarker | Q864574 | ||
| P304 | page(s) | e93046 | |
| P577 | publication date | 2014-04-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers | |
| P478 | volume | 9 |
| Q31107761 | A comparative evaluation of data-merging and meta-analysis methods for reconstructing gene-gene interactions |
| Q33761904 | AHNAK2 is a potential prognostic biomarker in patients with PDAC. |
| Q41525845 | Analysis of K-Ras Interactions by Biotin Ligase Tagging. |
| Q91666287 | Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target |
| Q38453611 | Cell cycle related genes up-regulated in human colorectal development predict the overall survival of late-stage colorectal cancer patients |
| Q31011613 | Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients |
| Q97905185 | Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial |
| Q36392698 | Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer |
| Q39152619 | Early detection of pancreatic cancer: Where are we now and where are we going? |
| Q52561810 | Exact association test for small size sequencing data |
| Q90087579 | Genome-wide bioinformatics analysis reveals CTCFL is upregulated in high-grade epithelial ovarian cancer |
| Q52576084 | Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma. |
| Q47243883 | Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets |
| Q36860719 | Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis |
| Q42134488 | Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease |
| Q52607475 | Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers |
| Q35903521 | Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer |
| Q35921899 | Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis |
| Q36276060 | Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia |
| Q31060752 | Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier |
| Q91923412 | Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach |
| Q38784810 | New developments in the early diagnosis of pancreatic cancer |
| Q88524981 | Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-β exposure |
| Q26748615 | Surgical and molecular pathology of pancreatic neoplasms |
| Q92107926 | Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition |
Search more.